Article
Scalable Production of Embryonic Stem Cell-Derived Cardiomyocytes
1 Aug 2003
Abstract excerpt
Cardiomyocyte transplantation could offer a new approach to replace scarred, nonfunctional myocardium in a diseased heart. Clinical application of this approach would require the ability to generate large numbers of donor cells. The purpose of this study was to develop a scalable, robust, and reproducible process to derive purified cardiomyocytes from genetically engineered embryonic stem (ES) cells. ES cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
